Clark Capital Management Group, Inc. Eli Lilly & CO Transaction History

Clark Capital Management Group, Inc.

$14.3 Billion
Q3 2024

A detailed history of Clark Capital Management Group, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Clark Capital Management Group, Inc. holds 125,409 shares of LLY stock, worth $100 Million. This represents 0.78% of its overall portfolio holdings.

Number of Shares

125,409

Previous 120,758 3.85%

Holding current value

$100 Million

Previous $109 Million 1.62%

% of portfolio

0.78%

Previous 0.82%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$772.14 - $960.02 $3.59 Million - $4.47 Million	4,651 Added 3.85%	125,409 $111 Million
Q2 2024 Aug 14, 2024	BUY	$724.87 - $909.04 $3.01 Million - $3.77 Million	4,148 Added 3.56%	120,758 $109 Million
Q1 2024 May 15, 2024	BUY	$592.2 - $792.28 $2.78 Million - $3.72 Million	4,696 Added 4.2%	116,610 $90.7 Million
Q4 2023 Feb 14, 2024	SELL	$525.19 - $619.13 $6.9 Million - $8.14 Million	-13,147 Reduced 10.51%	111,914 $65.2 Million
Q3 2023 Nov 14, 2023	BUY	$434.7 - $599.3 $155,187 - $213,950	357 Added 0.29%	125,061 $67.2 Million
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $3.15 Million - $4.21 Million	8,969 Added 7.75%	124,704 $58.5 Million
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $5.09 Million - $5.98 Million	-16,385 Reduced 12.4%	115,735 $39.7 Million
Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $10.1 Million - $11.8 Million	-31,361 Reduced 19.18%	132,120 $48.3 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $5.43 Million - $6.18 Million	18,303 Added 12.61%	163,481 $52.9 Million
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $6.63 Million - $7.78 Million	23,771 Added 19.58%	145,178 $47.1 Million
Q1 2022 May 16, 2022	BUY	$234.69 - $291.66 $366,116 - $454,989	1,560 Added 1.3%	121,407 $34.8 Million
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $13.6 Million - $16.8 Million	-60,369 Reduced 33.5%	119,847 $33.1 Million
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $39.2 Million - $48.2 Million	176,711 Added 5041.68%	180,216 $41.6 Million
Q2 2021 Aug 02, 2021	SELL	$180.55 - $233.54 $587,329 - $759,705	-3,253 Reduced 48.14%	3,505 $804,000
Q1 2021 May 17, 2021	BUY	$164.32 - $212.72 $72,958 - $94,447	444 Added 7.03%	6,758 $1.26 Million
Q4 2020 Jan 26, 2021	BUY	$130.46 - $172.63 $2,217 - $2,934	17 Added 0.27%	6,314 $1.07 Million
Q3 2020 Nov 12, 2020	SELL	$146.22 - $169.13 $72,963 - $84,395	-499 Reduced 7.34%	6,297 $932,000
Q2 2020 Aug 14, 2020	SELL	$136.42 - $164.18 $509,665 - $613,376	-3,736 Reduced 35.47%	6,796 $1.12 Million
Q1 2020 May 15, 2020	BUY	$119.05 - $147.35 $184,884 - $228,834	1,553 Added 17.3%	10,532 $1.46 Million
Q4 2019 Jan 27, 2020	BUY	$106.92 - $132.43 $38,277 - $47,409	358 Added 4.15%	8,979 $1.18 Million
Q3 2019 Nov 06, 2019	BUY	$106.79 - $116.16 $541,104 - $588,582	5,067 Added 142.57%	8,621 $964,000
Q2 2019 Jul 12, 2019	BUY	$110.79 - $129.32 $80,987 - $94,532	731 Added 25.89%	3,554 $394,000
Q1 2019 May 08, 2019	SELL	$111.31 - $131.02 $151,047 - $177,794	-1,357 Reduced 32.46%	2,823 $366,000
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $50,196 - $56,235	474 Added 12.79%	4,180 $484,000
Q3 2018 May 08, 2019	SELL	$85.86 - $107.31 $3,262 - $4,077	-38 Reduced 1.01%	3,706 $398,000
Q3 2018 Nov 14, 2018	BUY	$85.86 - $107.31 $3,262 - $4,077	38 Added 1.03%	3,744 $402,000
Q1 2018 May 08, 2019	SELL	$74.21 - $87.6 $14,841 - $17,520	-200 Reduced 5.12%	3,706 $287,000
Q1 2018 May 15, 2018	BUY	$74.21 - $87.6 $289,864 - $342,165	3,906 New	3,906 $302,000

Others Institutions Holding LLY

# of Institutions

4,007

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $760B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clark Capital Management Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Clark Capital Management Group, Inc. with notifications on news.

Account

Clark Capital Management Group, Inc. Eli Lilly & CO Transaction History